Arrive: A retrospective registry of Indian patients with venous thromboembolism.

Indian J Crit Care Med

Ex-Area Medical Head, Developing Countries- Asia, GlaxoSmithKline Pharmaceuticals, Mumbai, Maharashtra, India.

Published: March 2016

AI Article Synopsis

  • This study aimed to fill the gap in knowledge about venous thromboembolism (VTE) in India by analyzing data from 549 patients who were diagnosed between 2006 and 2010.
  • The majority of patients suffered from acute deep vein thrombosis (DVT), with significant contributing factors being a history of DVT, recent surgery, and prolonged immobilization.
  • Most patients received anticoagulant treatment, primarily with heparin, and the study found a rising annual incidence of DVT, indicating a growing public health concern.

Article Abstract

Background And Aim: There is lack of substantial Indian data on venous thromboembolism (VTE). The aim of this study was to provide real-world information on patient characteristics, management strategies, clinical outcomes, and temporal trends in VTE.

Subjects And Methods: Multicentre retrospective registry involving 549 medical records of patients with confirmed diagnosis of VTE (deep vein thrombosis [DVT] confirmed by Doppler ultrasonography; pulmonary embolism [PE] by computed tomography, pulmonary angiography and/or V/Q scan) from 2006 to 2010 at three Indian tertiary care hospitals.

Results: Acute DVT without PE, acute DVT with PE, and PE alone were reported in 64% (352/549), 23% (124/549), and 13% (73/549) patients, respectively. Mean age was 47 (±16) years, and 70% were males. H/o DVT (34%), surgery including orthopedic surgery (28%), trauma (16%), and immobilization >3 days (14%) were the most common risk factors for VTE. Hypertension (25%), diabetes (19%), and neurological disease (other than stroke) (8%) were the most common co-morbidities. Most (94%) were treated with heparin alone (82%) or fondaparinux (2%) for initial anticoagulation; low molecular weight heparin alone (5%) or warfarin/acenocoumarol (76%) for long-term anticoagulation. Anticoagulant treatment was stopped because of bleeding in 2% (9/515) patients. Mortality was 7% among patients diagnosed with VTE during hospital stay versus 1% in those hospitalized with diagnosed VTE. The annual incidence of DVT (±PE) increased from 2006 to 2010.

Conclusion: Acute DVT alone was responsible for the substantial burden of VTE in Indian patients. Bleeding was not the limiting factor for anticoagulant treatment in most patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810892PMC
http://dx.doi.org/10.4103/0972-5229.178178DOI Listing

Publication Analysis

Top Keywords

acute dvt
12
retrospective registry
8
indian patients
8
venous thromboembolism
8
anticoagulant treatment
8
diagnosed vte
8
patients
7
vte
6
dvt
5
arrive retrospective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!